Camlin Fine Sciences Profile
Key Indicators
- Authorised Capital ₹ 21.50 Cr
- Paid Up Capital ₹ 16.75 Cr
- Company Age 31 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 663.58 Cr
- Satisfied Charges ₹ 1,187.59 Cr
- Revenue Growth 16.30%
- Profit Growth 212.39%
- Ebitda 29.84%
- Net Worth 27.49%
- Total Assets 26.18%
About Camlin Fine Sciences
Camlin Fine Sciences Limited (CFSL) is a leading Public Limited Indian Non-Government Company incorporated in India on 30 November 1993 and has a history of 31 years and two months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532834 and on the National Stock Exchange(NSE) under CAMLINFINE.
The Corporate was formerly known as Camlin Fine Chemicals Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 21.50 Cr and a paid-up capital of Rs 16.75 Cr.
The company currently has active open charges totaling ₹663.58 Cr. The company has closed loans amounting to ₹1,187.59 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Camlin Fine Sciences Limited India are Santosh Parab as CFO and Rahuldashrath Sawale as Company Secretary. Josephconrad Dsouza, Amol Shah, Pradip Kanakia, and Seven other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L74100MH1993PLC075361
- Company No.
075361
- Stock Symbol
BSE : 532834 NSE : CAMLINFINE
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Nov 1993
- Date of AGM
31 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Camlin Fine Sciences Limited offer?
Camlin Fine Sciences Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Organic Compounds, Ketones, Tert-Butylhydroquinone TBHQ, Organic and Inorganic Solvents, Confectionery Ingredients, Bakery Ingredients, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Flavours & Aromatics.
Who are the key members and board of directors at Camlin Fine Sciences?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Parab  | CFO | 10-Feb-2017 | Current |
| Ashish Dandekar | Managing Director | 11-Jan-2007 | Current |
| Nirmal Momaya | Managing Director | 04-Aug-2014 | Current |
| Rahuldashrath Sawale | Company Secretary | 12-Nov-2021 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sutapa Banerjee | Director | 08-Feb-2020 | Current |
| Harsha Raghavan | Director | 10-Aug-2020 | Current |
| Mahabaleshwar Palekar | Director | 24-Dec-2020 | Current |
| Arjun Dukane | Whole-Time Director | 01-Jun-2018 | Current |
| Amol Shah | Director | 02-Aug-2019 | Current |
| Josephconrad Dsouza | Director | 28-Sep-2020 | Current |
Financial Performance of Camlin Fine Sciences.
Camlin Fine Sciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.3% increase. The company also saw a substantial improvement in profitability, with a 212.39% increase in profit. The company's net worth Soared by an impressive increase of 27.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Camlin Fine Sciences?
In 2023, Camlin Fine Sciences had a promoter holding of 17.55% and a public holding of 82.44%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sona Blw Precision Forgings LimitedPradip Kanakia is a mutual person
Onward Technologies LimitedHarsha Raghavan is a mutual person
Eris M. J. Biopharm Private LimitedAmol Shah is a mutual person
Focussed Event Management Private LimitedAshish Dandekar is a mutual person
Chemolutions Chemicals LimitedArjun Dukane is a mutual person
Fine Aroma Specialities Private LimitedAmol Shah is a mutual person
Charges (Loans)
₹663.58 Cr
₹1,187.59 Cr
Charges Breakdown by Lending Institutions
- Sbicap Trustee Company Limited : 456.15 Cr
- Idbi Trusteeship Services Limited : 110.00 Cr
- Others : 96.65 Cr
- Hdfc Bank Limited : 0.78 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2023 | Hdfc Bank Limited | ₹4.40 M | Open |
| 01 Sep 2022 | Others | ₹1.65 Cr | Open |
| 21 Jul 2022 | Others | ₹95.00 Cr | Open |
| 20 May 2022 | Hdfc Bank Limited | ₹3.43 M | Open |
| 22 Jan 2021 | Idbi Trusteeship Services Limited | ₹110.00 Cr | Open |
How Many Employees Work at Camlin Fine Sciences?
Camlin Fine Sciences has a workforce of 612 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Camlin Fine Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Camlin Fine Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
